Prof. Dr. med. Peter Fasching

Professur für Translationale Frauenheilkunde und Geburtshilfe

Genetic variants in the genes of the stress hormone signalling pathway and depressive symptoms during and after pregnancy (2014) Schneider M, Engel A, Fasching P, Haeberle L, Binder EB, Voigt F, Grimm J, et al. Journal article Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study (2014) Koebel M, Madore J, Ramus SJ, Clarke BA, Pharoah PDP, Deen S, Bowtell DD, et al. Journal article MicroRNA Related Polymorphisms and Breast Cancer Risk (2014) Khan S, Greco D, Michailidou K, Milne RL, Muranen TA, Heikkinen T, Aaltonen K, et al. Journal article Molecular profiling of single circulating tumor cells with diagnostic intention (2014) Polzer B, Medoro G, Pasch S, Fontana F, Zorzino L, Pestka A, Andergassen U, et al. Journal article Pooled analysis of the prognostic relevance of progesterone receptor status in five German cohort studies (2014) Salmen J, Neugebauer J, Fasching P, Häberle L, Huober J, Woeckel A, Rauh C, et al. Journal article FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium (2014) Agarwal D, Pineda S, Michailidou K, Herranz J, Pita G, Moreno LT, Alonso MR, et al. Journal article Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation (2014) Ghoussaini M, Edwards SL, Michailidou K, Nord S, Lari RCS, Desai K, Kar S, et al. Journal article Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium (2014) Milne RL, Burwinkel B, Michailidou K, Arias-Perez JI, Pilar Zamora M, Menendez-Rodriguez P, Hardisson D, et al. Journal article Surgical outcome after neoadjuvant chemotherapy and bevacizumab: results from the GeparQuinto study (GBG 44) (2014) Gerber B, Von Minckwitz G, Eidtmann H, Rezai M, Fasching P, Tesch H, Eggemann H, et al. Journal article Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40--GeparQuattro) (2014) Von Minckwitz G, Rezai M, Fasching P, Huober J, Tesch H, Bauerfeind I, Hilfrich J, et al. Journal article